Results 91 to 100 of about 26,399 (169)

Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo

open access: yes, 2018
Current efforts toward human immunodeficiency virus (HIV) eradication include approaches to augment immune recognition and elimination of persistently infected cells following latency reversal.
Carolina Garrido   +6 more
core   +1 more source

Croton oligandrus Pierre & Hutch (Euphorbiaceae) Extracts and Isolated Compounds Reverse HIV-1 Latency

open access: yesJournal of Experimental Pharmacology
Chantal Emade Nkwelle,1,2 Smith B Babiaka,3,4 Clovis S Metuge,2,3 Kimberly Liang,5 Unique Stephens,5 Seraphine Nkie Esemu,1 David S Zuzga,5 Kristy Shuda McGuire,5 Luis J Montaner,5 Roland N Ndip,1 Ian Tietjen,5 Fidele Ntie-Kang2,3,6 1Department of ...
Emade Nkwelle C   +11 more
doaj  

High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells

open access: yesScientific Reports
Maraviroc (MVC) is an antiretroviral drug capable of binding to CCR5 receptors and block HIV entry into target cells. Moreover, MVC can activate NF-kB pathway and induce viral transcription in HIV-infected cells, being proposed as a latency reversal ...
Erick De La Torre Tarazona   +4 more
doaj   +1 more source

Ansellone J, a Potent in Vitro and ex Vivo HIV‑1 Latency Reversal Agent Isolated from a Phorbas sp. Marine Sponge

open access: yes
Five new minor sesterterpenoids, ansellones H (4), I (5), J (6), and K (7) and phorone C (8), have been isolated from a Phorbas sp. marine sponge collected in British Columbia. Their structures have been elucidated by detailed analysis of NMR and MS data.
Raymond J. Andersen (155984)   +12 more
core   +1 more source

Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo

open access: yesMicrobiology Spectrum
Latency reversal and subsequent elimination of the human immunodeficiency virus-1 (HIV-1) reservoir using a combination of compounds with different mechanisms of action are considered a promising tool for HIV-1 cure.
Jade Jansen   +8 more
doaj   +1 more source

The impact of heptose phosphates on HIV latency and human immune responses

open access: yes, 2023
Use of HIV-specific antiretroviral therapeutic agents (ARTs) achieves total control of viremia and prevents progression of HIV to AIDS, but they are not a cure.
Guvenc, Furkan
core  

Beyond Antiretroviral Therapy: Molecular and Immunological Innovations in HIV Treatment

open access: yesTropical Medicine and Infectious Disease
Despite prolonged viral inhibition with combination antiretroviral therapy (ART), HIV-1 survives as genetically intact, replication-capable proviruses within durable CD4+ T-cell fractions, involving central memory, transitional memory, and stem cell-like
Awadh Alanazi   +2 more
doaj   +1 more source

A truncated HIV Tat demonstrates potent and specific latency reversal activity. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Van Gulck E   +17 more
europepmc   +1 more source

How fast can we see? The latency development in human infants to pattern, orientation, and direction-reversal visual evoked potentials

open access: yes, 2012
The goal of this thesis is to track latency changes in three visual evoked potentials (VEP) stimuli as an indication of overall brain development, in order to provide a normative baseline to differentiate visual and neurological development from ...
Lee, Jin
core   +1 more source

HIV latency reversal using designed PKC modulators

open access: yesJournal of Virus Eradication, 2017
M.D. Marsden   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy